Erratum: Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.


Eyre T. A., Song Y., Hermine O., Shuang Y., Jurczak W., Farias J. S., ...Daha Fazla

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, cilt.44, sa.23, ss.2258, 2026 (SCI-Expanded, Scopus)